ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Stock Analyst Ratings

Europe • Euronext Paris • EPA:ALOPM • FR001400CM63

0.54 EUR
-0.03 (-4.93%)
Last: Feb 5, 2026, 07:00 PM
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to ALOPM.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 2.04. This target is 277.78% above the current price.
  • ALOPM.PA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALOPM.PA.
  • In the previous month the buy percentage consensus was at a similar level.
  • ALOPM.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
ALOPM.PA Historical Analyst RatingsALOPM.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.542.022.042.042.10 - 274.07% 277.78% 277.78% 288.89%

Related screens

Find peers 30% below price target
ALOPM.PA Current Analyst RatingALOPM.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades

ONCODESIGN PRECISION MEDICIN / ALOPM.PA FAQ

What is the average price target for ONCODESIGN PRECISION MEDICIN (ALOPM.PA) stock?

9 analysts have analysed ALOPM.PA and the average price target is 2.04 EUR. This implies a price increase of 277.78% is expected in the next year compared to the current price of 0.54.


What is the consensus rating for ONCODESIGN PRECISION MEDICIN (ALOPM.PA) stock?

The consensus rating for ONCODESIGN PRECISION MEDICIN (ALOPM.PA) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.